Related Experiment Video
Updated: Jul 27, 2025

Visual Detection of Multiple Nucleic Acids in a Capillary Array
Published on: November 15, 2017
Overview of Molecular Detection Technologies for
Carina Heydt1, Michaela Angelika Ihle1, Sabine Merkelbach-Bruse1
1Faculty of Medicine, Institute of Pathology, University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany.
Abstract:
MET tyrosine kinase receptor pathway activation has become an important actionable target in solid tumors. Aberrations in the MET proto-oncogene, including MET overexpression, the activation of MET mutations, MET mutations that lead to MET exon 14 skipping, MET gene amplifications, and MET fusions, are known to be primary and secondary oncogenic drivers in cancer; these aberrations have evolved as predictive biomarkers in clinical diagnostics. Thus, the detection of all known MET aberrations in daily clinical care is essential. In this review, current molecular technologies for the detection of the different MET aberrations are highlighted, including the benefits and drawbacks. In the future, another focus will be on the standardization of detection technologies for the delivery of reliable, quick, and affordable tests in clinical molecular diagnostics.
Insights
Detecting MET proto-oncogene aberrations is crucial for solid tumor treatment. This review covers molecular technologies for identifying MET alterations, essential for personalized cancer diagnostics and therapy.
Area of Science:
- Oncology
- Molecular Diagnostics
- Genetics
Background:
- MET tyrosine kinase receptor pathway activation is a key target in solid tumors.
- Aberrations in the MET proto-oncogene (overexpression, mutations, exon 14 skipping, amplifications, fusions) drive cancer.
- These MET aberrations serve as predictive biomarkers in clinical diagnostics.
Purpose of the Study:
- To review current molecular technologies for detecting various MET aberrations.
- To highlight the benefits and drawbacks of existing detection methods.
- To emphasize the importance of detecting all known MET aberrations in clinical practice.
Main Methods:
- Review of current molecular technologies for MET aberration detection.
- Analysis of benefits and drawbacks of each technology.
- Discussion on the role of these technologies in clinical diagnostics.
Main Results:
- Various molecular technologies exist for detecting MET aberrations.
- Each technology presents unique advantages and limitations.
- Accurate detection is essential for guiding targeted cancer therapies.
Conclusions:
- Comprehensive detection of MET aberrations is vital for effective cancer treatment.
- Standardization of detection technologies is needed for reliable, rapid, and affordable clinical tests.
- Future efforts should focus on improving and standardizing diagnostic tools for MET-driven cancers.
Related Concept Videos
Modern Molecular Taxonomy
DNA Microarrays
Methods of Classification and Identification
Labeling DNA Probes
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
Applications of Molecular Taxonomy
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....

